Gland Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gland Pharma Ltd (GLAD)
Track today's live Gland (GLAD) share price, performance and key data on this page with our current NSE:GLAD stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Gland share price on the NSE exchange. Use the dropdown to switch exchange for the GLAD share price, head to our technical summary section, which provides analysis on Gland share price buy/sell indicators using real-time data (or discuss the Gland (GLAD) stock price today with other investors in the Gland NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:GLAD share price (ISIN: INE068V01023) to enhance your trading decisions with our free investment tools and resources.
What Is the Gland Pharma Ltd Share Price Today?
The Gland share price today is 2,903.20.
What Is the Stock Symbol for Gland Pharma Ltd
The stock symbol (or 'ticker') for Gland Pharma Ltd is "GLAD."
What Stock Exchange Does Gland Pharma Ltd Trade On?
Gland Pharma Ltd is listed and trades on the NSE stock exchange.
Is Gland Pharma Ltd a Good Stock to Buy?
Determining whether Gland (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:GLAD share price (ISIN: INE068V01023) to enhance your trading decisions with our free investment tools and resources.
What Is the Gland Pharma Ltd Share Price Today?
The Gland share price today is 2,903.20.
What Is the Stock Symbol for Gland Pharma Ltd
The stock symbol (or 'ticker') for Gland Pharma Ltd is "GLAD."
What Stock Exchange Does Gland Pharma Ltd Trade On?
Gland Pharma Ltd is listed and trades on the NSE stock exchange.
Is Gland Pharma Ltd a Good Stock to Buy?
Determining whether Gland (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
2,903.20
+78.60(+2.78%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,831.40
2,915.00
52 wk Range
1,573.60
3,039.80
GLAD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,831.402,915.00
52 wk Range
1,573.603,039.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GLAD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
2,856.07
Downside
-1.62%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Grand Canal receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Gland Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
10 Buy
0 Hold
4 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2,856.07
(-1.62% Downside)
Earnings
Latest Release
10/08/2026
EPS / Forecast
19.22 / 17.26
Revenue / Forecast
18B / 17.49B
Compare GLAD to Peers and Sector
Metrics to compare | GLAD | Peers Peers - average of corresponding metrics from companies closely matching GLAD: ALKEM, CAPLIPOINT, AKUMS, GLENMARK, AJANTPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLADPeersSector |
|---|---|---|---|---|
P/E Ratio | 42.4x | 29.7x | −0.4x | |
PEG Ratio | 0.94 | 0.19 | 0.00 | |
Price/Book | 4.6x | 2.9x | 2.6x | |
Price / LTM Sales | 7.1x | 4.3x | 3.0x | |
Upside (Analyst Target) | 3.9% | 13.1% | 46.9% | |
Fair Value Upside | Unlock | 1.2% | 5.3% | Unlock |
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, and neurological and central nervous system; blood related, ophthalmics and otologicals, cardiac, gastro-intestinal, and hormonal products; pain, neuromuscular blocking agents, and analgesics; respiratory and pulmonology; and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier preparation, and technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Gland (NSE: GLAD) Share Price Today?
The Gland stock price today is 2,903.20 INR.
What Stock Exchange Does Gland (GLAD) Trade On?
Gland is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Gland?
The stock symbol (also called a 'ticker') for Gland is "GLAD."
Does Gland Pay Dividends? What’s The Current GLAD Dividend Yield?
Yes, GLAD Pays Dividends to its Shareholders. The current Gland dividend yield is 0.69%.
What Is the Current Gland Market Capitalisation?
As of today, Gland (NSE: GLAD) market cap is 478.93B INR.
What Is Gland's (GLAD) Earnings Per Share (TTM)?
The Gland EPS is currently 68.41 (Trailing Twelve Months).
When Is the Next Gland Earnings Date?
Gland's next earnings report will be released on 09/11/2026.
Is GLAD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Gland moving averages and other technical indicators, the daily buy/sell signal for GLAD stock is Strong Buy.
How Many Times Has Gland Stock Split?
Gland has split 0 times. (See the GLAD stock split history page for full effective split date and price information.)
How Many Employees Does Gland Have?
Gland has 4332 employees, based on their latest Companies House report.
What is the current trading status of Gland (NSE: GLAD)?
As of 26/08/2026, Gland (GLAD) is trading at a share price of 2,903.20 INR, with a previous close of 2,824.60 INR. The stock has fluctuated within a day range of 2,831.40 INR to 2,915.00 INR, while its 52-week range spans from 1,573.60 INR to 3,039.80 INR.
What Is Gland (GLAD) Price Target According to Analysts?
The average 12-month price target for Gland is 2,856.07 INR, with a high estimate of 3350 INR and a low estimate of 1940 INR. 10 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Buy. The stock has an -1.62% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.